12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 16.8% to $1.32 during Friday's after-market session. The company's market cap stands at $37.0 million.
Looking Into PLx Pharma’s Return On Capital Employed
Pulled from Benzinga Pro data, PLx Pharma (NASDAQ:PLXP) posted Q4 earnings of $3.56 million, an increase from Q3 of 116.46%. Sales dropped to $1.59 million, a 75.94% decrease between quarters.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 198 companies made new 52-week lows.
PLx Pharma Q4 EPS $(0.73) Misses $(0.71) Estimate, Sales $1.60M Miss $2.05M Estimate
PLx Pharma (NASDAQ:PLXP) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.71) by 2.82 percent. This is a 16.09 percent increase over losses of $(0.87) per share from the
Earnings Scheduled For March 11, 2022
Companies Reporting Before The Bell
• The Real Good Food (NASDAQ:RGF) is estimated to report quarterly loss at $0.19 per share on revenue of $25.29 million.
PLx Pharma’s Earnings Outlook
PLx Pharma (NASDAQ:PLXP) is set to give its latest quarterly earnings report on Friday, 2022-03-11. Here's what investors need to know before the announcement.
Analysts estimate that PLx Pharma will report an earnings per share (EPS) of $-0.71.
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
